Dietary counseling based on artificial intelligence for patients with nonalcoholic fatty liver disease

doi:10.35712/aig.v3.i4.105

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 4

This Article

(228)

(227)

(0)

(13)

(1)

(5330)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

Artificial Intelligence in Gastroenterology

ISSN

2644-3236

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Prospective Study

Artif Intell Gastroenterol. Oct 28, 2022; 3(4): 105-116
Published online Oct 28, 2022. doi: 10.35712/aig.v3.i4.105

Table 1 Patients' characteristics (n = 29)

Male/Female	16/13
Age (yr)	56.4 ± 14.3
Body weight (kg)	74.1 ± 13.1
BMI (kg/m²)	28.4 ± 5.2
Metabolic diseases
Diabetes mellitus (Yes/No)	10/19
Dyslipidemia (Yes/No)	14/15
Concomitant drugs
SGLT2 inhibitor	2
DPP-4 inhibitor	3
Thiazolidinedione
GLP-1 agonist	1
Statin	7
Bezafibrate
Pemafibrate
EPA and DHA preparation	1
AST (U/L)	50.2 ± 33.4
ALT (U/L)	53.8 ± 39.0
GGT (U/L)	80.3 ± 84.3
T-B (mg/dL)	1.3 ± 0.9
Alb (mg/dL)	4.2 ± 0.6
eGFR (mL/min)	71.1 ± 11.5
HbA1c (%)	6.4 ± 0.8
T-cho (mg/dL)	191.3 ± 35.0
TG (mg/dL)	126.5 ± 57.8
WBC (10³/μL)	5.6 ± 1.5
Hb (g/dL)	14.5 ± 1.7
Plts (10⁴/μL)	17.7 ± 7.4

AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; GGT: γ-Glutamyltransferase; T-Bil: Total bilirubin; Alb: Albumin; eGFR: Estimated glomerular filtration rate; HbA1c: Glycated hemoglobin A1c; T-chol: Total cholesterol; TG: Triglycerides; WBC: White blood cells; Hb: Hemoglobin; Plts: Platelets.

Full Size Table

Citation: Kusano Y, Funada K, Yamaguchi M, Sugawara M, Tamano M. Dietary counseling based on artificial intelligence for patients with nonalcoholic fatty liver disease. Artif Intell Gastroenterol 2022; 3(4): 105-116
URL: https://www.wjgnet.com/2644-3236/full/v3/i4/105.htm
DOI: https://dx.doi.org/10.35712/aig.v3.i4.105

Kusano Y, Funada K, Yamaguchi M, Sugawara M, Tamano M. Dietary counseling based on artificial intelligence for patients with nonalcoholic fatty liver disease. Artif Intell Gastroenterol 2022; 3(4): 105-116 [DOI: 10.35712/aig.v3.i4.105]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.